4 Followers on Owler
OverviewCompetitorsFundingNews & Insights

INmune Bio Competitors or Alternatives

INmune Bio's top competitors include Cellerant, Fate Therapeutics and Ambrx.

Unlock 31 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

INmune Bio's company profile

Raymond J. Tesi

President & CEO

89/100
10
$97.9M
$ < 1M
  • $97.9M
    $ < 1M
  • 10
    $97.9M
  • $ < 1M
  • 89/100
  • 10
  • $97.9M
  • $ < 1M
View ProfileView
1
INmune Bio's Competitor - Cellerant logo

Ram Mandalam

President & CEO

90/100
25 - 100
$153.9M
$5M - 25M
  • $153.9M
    $5M - 25M
  • 25 - 100
    $153.9M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $153.9M
  • $5M - 25M
View ProfileView
2
INmune Bio's Competitor - Fate Therapeutics logo

Bahram Valamehr

President & CEO

82/100
550
$366.3M
$6.3M
  • $366.3M
    $6.3M
  • 550
    $366.3M
  • $6.3M
  • 82/100
  • 550
  • $366.3M
  • $6.3M
View ProfileView
3
INmune Bio's Competitor - Ambrx logo

Daniel J. OConnor

CEO

82/100
25 - 100
$717.2M
$100K - 5M
  • $717.2M
    $100K - 5M
  • 25 - 100
    $717.2M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $717.2M
  • $100K - 5M
View ProfileView
4
INmune Bio's Competitor - Glycostem logo

Troels Jordansen

CEO

90/100
25 - 100
$15.4M
$5M - 25M
  • $15.4M
    $5M - 25M
  • 25 - 100
    $15.4M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $15.4M
  • $5M - 25M
View ProfileView
5
INmune Bio's Competitor - Redx Pharma logo

Lisa Anson

CEO

90/100
71
$120.4M
$13.5M
  • $120.4M
    $13.5M
  • 71
    $120.4M
  • $13.5M
  • 90/100
  • 71
  • $120.4M
  • $13.5M
View ProfileView
INmune Bio's top 34 competitors are Cellerant, Fate Therapeutics, Ambrx, bluebird bio, Glycostem, Redx Pharma, Agenus, Lilly, Calithera, Juno Therapeutics, BioVision, Immunocore, Dimension Therapeutics, Trianni, Lysogene, Calimmune, BioLegend, Agalimmune, Agilis Biotherapeutics, Sharp Edge, Spark Therapeutics, Novodiax, Imara, Phoremost, Antagene, Inc., AVEO, Roche, Sage Therapeutics, GeneTex, Lonza, NexImmune, Perthera, ImmunGene and Merck. Together they have raised over 32.7B between their estimated 236.5K employees. INmune Bio has 10 employees and is ranked 35th among it's top 10 competitors. The top 10 competitors average 6,757.

INmune Bio VS Cellerant

Cellerant has been one of INmune Bio's top competitors. Cellerant was founded in 2003, and is headquartered in Newark, California. Cellerant competes in the Biotechnology industry. Cellerant generates $8.4M more revenue vs. INmune Bio.

INmune Bio VS Fate Therapeutics

Fate Therapeutics is a top competitor of INmune Bio. Fate Therapeutics is a Public company that was founded in San Diego, California in 2007. Like INmune Bio, Fate Therapeutics also competes in the Biotechnology industry. Fate Therapeutics has 540 more employees vs. INmune Bio.

INmune Bio VS Ambrx

Ambrx is perceived as one of INmune Bio's biggest rivals. Ambrx was founded in 2003, and its headquarters is in San Diego, California. Like INmune Bio, Ambrx also operates in the Biotechnology field. Ambrx has 57 more employees than INmune Bio.

Looking for similar companies to INmune Bio?

Similar Companies

Biotechnology companies in Boca Raton

See 24 companies 
Biotechnology companies in Miami Metropolitan Area

See 227 companies 
Pharmaceuticals & Biotechnology companies in Boca Raton

See 46 companies 
Pharmaceuticals & Biotechnology companies in Miami Metropolitan Area

See 420 companies 
Biotechnology companies in Florida

See 551 companies 
Companies in Boca Raton with employees in 1-25 range

See 831 companies 
Pharmaceuticals & Biotechnology companies in Florida

See 980 companies 
Biotechnology companies with employees in 1-25 range

See 3,318 companies 
Pharmaceuticals & Biotechnology companies with employees in 1-25 range

See 4,703 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for INmune Bio and INmune Bio's Competitors

June 10, 2026NDTV
Patients who took Foundayo 17.2 mg lost an average of 19.7 pounds....
June 9, 2026Marketscreener
AlzeCure signs collaboration, out-licensing deal with Lilly for Alzheimer's drugAlzeCure Pharma said on Tuesday it had entered a collaboration and out-...
June 9, 2026FierceBiotechIT
Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for u...

Frequently Asked Questions about INmune Bio

  1. Who are INmune Bio's top competitors?

    INmune Bio's top 3 competitors are Cellerant, Fate Therapeutics, Ambrx.

  2. Who is similar to INmune Bio?

    Cellerant is the most similar to INmune Bio. Fate Therapeutics and Ambrx are also similar to INmune Bio.

  1. Are INmune Bio and Cellerant competitors?

    Yes, Cellerant is one of INmune Bio’s top competitors.